Pamela Anderson’s Hepatitis; Statins After Colon Cancer; Fall Vaccines in Gastro/Hep

Pamela Anderson recently opened up about her experience with hepatitis C. The actress was diagnosed in the 1990s and in 2015 said she was free of the disease. (ABC News)

A study in JAMA Internal Medicine showed that a correctional facility policy requiring individuals to opt out of hepatitis C testing can increase testing frequency and subsequent treatment, particularly for individuals with addiction issues.

Statin initiation following initial colorectal cancer (CRC) treatment was associated with a 5% reduction in CRC-specific mortality but not all-cause mortality in a Korean study. (JAMA Network Open)

Neptune Medical said the FDA cleared its robotic Triton 1 System, a flexible endoscopy system that’s designed to reach anywhere in the colon during diagnostic and therapeutic procedures.

A meta-analysis of randomized trials showed that cold resection for large non-pedunculated colorectal polyps led to fewer major adverse events versus hot snare resections but was associated with more residual or recurrent adenomas. (Gut)

The 2020 guidelines update on post-polypectomy surveillance appears to have improved endoscopist adherence to recommended follow-up intervals for patients with one or two non-advanced adenomas. (Clinical Gastroenterology and Hepatology)

A large meta-analysis linked attention deficit-hyperactivity disorder to an increased likelihood of several gastrointestinal issues, including irritable bowel syndrome, constipation, and encopresis. (Journal of Attention Disorders)

An oral live biotherapeutic product containing Faecalibacterium prausnitzii EXL01 showed promise for recurrent Clostridioides difficile infections in a small preliminary study. (Gastroenterology)

For patients with chronic pancreatitis, non-enteric-coated pancreatic enzyme replacement therapy failed to top placebo for easing chronic abdominal pain, a randomized trial found. (Gut)

Leading U.S. gastroenterology and hepatology organizations issued a joint statement recommending annual flu and COVID vaccines for people with gastrointestinal and liver diseases, the American Gastroenterological Association announced.

Researchers in Clinical Gastroenterology and Hepatology looked at potential biological mechanisms to explain the link between ultraprocessed food and increased Crohn’s disease risk.

A report in Inflammatory Bowel Diseases described a particular adipose tissue profile in pediatric Crohn’s disease characterized by a normal body mass index and hepatic fat but increased visceral and subcutaneous adipose tissue — or thin on the outside, fat on the inside Crohn’s-associated obesity (TOFICO).

Clues on microbiome correlations in predicting necrotizing enterocolitis. (Gut)

Certain microbial features were associated with better survival outcomes for advanced hepatocellular carcinoma patients on immunotherapy. (Gut)

A narrative review in Gastro Hep Advances examined how climate change could impact kids’ gastrointestinal health.